ja_mageia

A Preclinical Consortium, Grant Awards and Toolbox to Accelerate Candidate NF Drug Screening

There is currently no effective drug treatment for neurofibromatosis (NF). To help change that, the Drug Discovery Initiative (DDI) funds and facilitates preclinical screening of candidate treatments for NF.

DDI NF Preclinical Consortium: An ongoing $7M program to accelerate the identification of effective drug therapies, testing candidate NF drugs in multiple tumor models of NF. For more information, please click here.

Drug Discovery Initiative (DDI) Awards: Individual grants to fund pilot-stage preclinical drug testing.

NEW for 2012 DDI Amounts INCREASED!

- $30,000 for in vitro drug testing/screens

- $50,000 for in vivo drug testing/screens

DDI Advanced Awards: Advanced in vivo funding of up to $75,000. Applications accepted only by invitation from CTF, from individuals who have previously received an in vivo DDI Award. For more information contact CTF. 

2011 DDI Award deadlines:
- February 28, 2012
- August 31, 2012

Click here to view full application and RFA.

DDI Toolbox: An online listing of ‘tools’ and partnering forum for NF drug screening. If you have an NF screening model (cells, animal models) – or a drug you’d like to see tested for NF efficacy – submit them for listing in the DDI Toolbox. Click here to see the latest Toolbox listings.

Toolbox Submissions are accepted on a rolling basis
Download the DDI Toolbox Submissions Information

Questions? Contact:

Kim Hunter-Schaedle, Ph.D.
Chief Scientific Officer
Children's Tumor Foundation
95 Pine Street, 16th Floor
New York, NY 10005
Tel: 212-344-6633 x 231
Email: \n This e-mail address is being protected from spambots. You need JavaScript enabled to view it